Enasidenib therapy in FLT3-ITD + /IDH2 R140Q double mutated mice model decreased the 2-HG serum levels and induced demethylation of the hypermethylated promoters in leukemia-derived cells. The gene discussed is FLT3; the disease is leukemia.